![Troy Ignelzi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Troy Ignelzi
Director of Finance/CFO at
RAPPORT THERAPEUTICS, INC.
Net worth: 395 000 $ as of 2026-05-30
Profile
Troy A. Ignelzi is currently Chairman at Vedanta Biosciences, Inc. since 2020.
He is Director at Abivax SA starting in 2023.
He is Independent Director at Harmony Biosciences Holdings, Inc. beginning in 2026.
He is Independent Director at Contineum Therapeutics, Inc. starting in 2024.
He is Chief Financial Officer at Rapport Therapeutics, Inc. since 2023.
Formerly, Mr. Ignelzi was Independent Director at CinCor Pharma, Inc. from 2021 to 2023.
He was Chief Financial Officer at Karuna Therapeutics, Inc. from 2019 to 2023.
He was Chief Financial & Accounting Officer at scPharmaceuticals, Inc. from 2016 to 2019.
He was Chief Financial Officer at Juventas Therapeutics, Inc. from 2014 to 2016.
He was Senior VP-Operations & Business Development at PharmaLex GmbH from 2013 to 2014.
He was Vice President-Business Development at Esperion Therapeutics, Inc. from 2009 to 2013.
He was VP-Business Development & Strategic Planning at InSys Therapeutics, Inc. from 2007 to 2009.
Education includes undergraduate studies at Ferris State University (Michigan).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-13 | 10,000 ( 0.02% ) | 395 000 $ | 2026-05-30 | |
| 2026-04-16 | 0 ( -.--% ) | - $ | 2026-05-30 | |
| 2026-04-01 | 0 ( -.--% ) | - $ | 2026-05-30 | |
ABIVAX SA -.--% | 2026-02-27 | 0 ( -.--% ) | - $ | 2026-05-30 |
Troy Ignelzi active positions
| Companies | Position | Start |
|---|---|---|
| ABIVAX | Director/Board Member | 2023-07-10 |
| RAPPORT THERAPEUTICS, INC. | Director of Finance/CFO | 2023-10-31 |
| CONTINEUM THERAPEUTICS, INC. | Director/Board Member | 2024-05-19 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Director/Board Member | 2026-04-01 |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Chairman | - |
Former positions of Troy Ignelzi
| Companies | Position | End |
|---|---|---|
| KARA THER | Director of Finance/CFO | 2023-09-28 |
| CINCOR PHARMA, INC. | Director/Board Member | 2023-02-23 |
| SCPHARMACEUTICALS INC. | Director of Finance/CFO | 2019-02-27 |
Juventas Therapeutics, Inc.
 Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Director of Finance/CFO | 2016-01-31 |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Troy Ignelzi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Ferris State University (Michigan)
 Ferris State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InSys Therapeutics, Inc. /Old/
 InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products | Health Technology |
Juventas Therapeutics, Inc.
Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Health Services |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
PharmaLex GmbH
 PharmaLex GmbH Packaged SoftwareTechnology Services Develops AI and machine learning automation for pharmacy, biotech & med tech industries | Technology Services |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
- Stock Market
- Insiders
- Troy Ignelzi
